...
首页> 外文期刊>Journal of biomedical materials research, Part A >Incorporation of bioactive glass in calcium phosphate cement: material characterization and in vitro degradation.
【24h】

Incorporation of bioactive glass in calcium phosphate cement: material characterization and in vitro degradation.

机译:将生物活性玻璃掺入磷酸钙水泥中:材料表征和体外降解。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Calcium phosphate cements (CPCs) have been widely used as an alternative to biological grafts due to their excellent osteoconductive properties. Although degradation has been improved by using poly(D,L-lactic-co-glycolic) acid (PLGA) microspheres as porogens, the biological performance of CPC/PLGA composites is insufficient to stimulate bone healing in large bone defects. In this context, the aim of this study was to investigate the effect of incorporating osteopromotive bioactive glass (BG; up to 50 wt %) on setting properties, in vitro degradation behavior and morphological characteristics of CPC/BG and CPC/PLGA/BG. The results revealed that the initial and final setting time of the composites increased with increasing amounts of incorporated BG. The degradation test showed a BG-dependent increasing effect on pH of CPC/BG and CPC/PLGA/BG pre-set scaffolds immersed in PBS compared to CPC and CPC/PLGA equivalents. Whereas no effects on mass loss were observed for CPC and CPC/BG pre-set scaffolds, CPC/PLGA/BG pre-set scaffolds showed an accelerated mass loss compared with CPC/PLGA equivalents. Morphologically, no changes were observed for CPC and CPC/BG pre-set scaffolds. In contrast, CPC/PLGA and CPC/PLGA/BG showed apparent degradation of PLGA microspheres and faster loss of integrity for CPC/PLGA/BG pre-set scaffolds compared with CPC/PLGA equivalents. Based on the present in vitro results, it can be concluded that BG can be successfully introduced into CPC and CPC/PLGA without exceeding the setting time beyond clinically acceptable values. All injectable composites containing BG had suitable handling properties and specifically CPC/PLGA/BG showed an increased rate of mass loss. Future investigations should focus on translating these findings to in vivo applications.
机译:磷酸钙水泥(CPC)由于其优异的骨传导性能而被广泛用作生物移植物的替代品。尽管通过使用聚(D,L-乳酸-乙醇酸共聚物)(PLGA)微球作为致孔剂可以改善降解,但是CPC / PLGA复合材料的生物学性能不足以刺激大骨缺损中的骨愈合。在这种情况下,本研究的目的是研究掺入骨促进生物活性玻璃(BG;含量不超过50 wt%)对CPC / BG和CPC / PLGA / BG的凝结特性,体外降解行为和形态特征的影响。结果表明,复合材料的初始和最终凝固时间随掺入的BG量的增加而增加。降解测试表明,与CPC和CPC / PLGA等价物相比,BG对浸泡在PBS中的CPC / BG和CPC / PLGA / BG预设支架的pH依赖性增加。尽管没有观察到CPC和CPC / BG预设脚手架对质量损失的影响,但CPC / PLGA / BG预设脚手架与CPC / PLGA等效物相比显示出加速的质量损失。在形态上,未观察到CPC和CPC / BG预设支架的变化。相反,CPC / PLGA和CPC / PLGA / BG与PLC / PLGA等价物相比,显示出PLGA微球的明显降解和CPC / PLGA / BG预设支架的完整性丧失得更快。根据目前的体外结果,可以得出结论,BG可以成功引入CPC和CPC / PLGA,而不会超过临床可接受的设定时间。所有含BG的可注射复合材料均具有合适的处理性能,特别是CPC / PLGA / BG表现出更高的质量损失率。未来的研究应集中于将这些发现转化为体内应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号